Mindfulness for Cardiovascular Disease Risk
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how mindfulness training during pregnancy might reduce the risk of cardiovascular disease (heart-related issues) for both mothers and their babies. Researchers aim to understand how mothers and infants respond to and recover from stress after mindfulness training and whether these responses relate to future heart health. The trial includes mothers who are six months postpartum and participated in a previous mindfulness study during pregnancy. Ideal candidates for this trial are mothers from the earlier study who had a single pregnancy and were at moderate to high risk for preeclampsia (a pregnancy complication characterized by high blood pressure).
As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve heart health for future generations.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It might be best to discuss this with the trial coordinators or your doctor.
What prior data suggests that prenatal mindfulness training is safe for mothers and infants?
Research on mindfulness training, including during pregnancy, suggests it is generally safe. Although few studies have focused on side effects, no major safety problems have emerged. Mindfulness training can lower blood pressure in individuals with hypertension and has shown benefits for pregnant women at risk of high blood pressure issues. This indicates it is well-tolerated and safe to try.12345
Why are researchers excited about this trial?
Researchers are excited about prenatal mindfulness training for cardiovascular disease risk because it offers a holistic approach that traditional medical treatments, like medication or lifestyle changes, typically do not address. This treatment emphasizes mental and emotional well-being during pregnancy, potentially reducing stress-related factors that contribute to hypertensive disorders. Additionally, it strengthens the parent-child bond post-birth, which may have long-term benefits for both. By incorporating mindfulness, this approach could offer a unique, non-invasive complement to existing cardiovascular risk management strategies.
What evidence suggests that prenatal mindfulness training might be an effective treatment for cardiovascular disease risk?
Research has shown that mindfulness training during pregnancy can help lower blood pressure, particularly for those with slightly high or high levels. In this trial, participants who previously took part in a mindfulness arm or treatment as usual (TAU) during a prenatal mindfulness RCT will be assessed using the Still Face Paradigm. Studies suggest that mindfulness training helps manage stress and may prevent high blood pressure from returning in pregnant women. In past research, women at risk for pregnancy-related high blood pressure who participated in mindfulness training experienced better blood pressure and healthier baby growth. Participants also became more aware of their body and breathing, which helped them notice changes in blood pressure. These findings suggest that mindfulness training could reduce heart disease risk for both mothers and their children.12367
Are You a Good Fit for This Trial?
This trial is for mothers and infants who were part of a previous study on mindfulness during pregnancy. Participants must be over 18, speak English, not currently pregnant, and have been at 'moderate' to 'high' risk for preeclampsia but normotensive when they enrolled in the earlier study.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Prenatal Mindfulness Training
Participants undergo mindfulness training during pregnancy to prevent hypertensive disorders
Postpartum Stress Reactivity Assessment
Maternal-infant physiological reactivity to stress is assessed using the Still Face Paradigm at 6 months postpartum
Follow-up
Maternal and infant cardiovascular risk is measured at 12 months postpartum
What Are the Treatments Tested in This Trial?
Interventions
- Prenatal Mindfulness training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lifespan
Lead Sponsor
National Institute of General Medical Sciences (NIGMS)
Collaborator